366.33
price up icon0.14%   0.13
 
loading

Amgen Inc 주식(AMGN)의 최신 뉴스

pulisher
06:34 AM

Amgen Inc. $AMGN Shares Sold by Savvy Advisors Inc. - MarketBeat

06:34 AM
pulisher
06:34 AM

LSV Asset Management Raises Holdings in Amgen Inc. $AMGN - MarketBeat

06:34 AM
pulisher
06:24 AM

Krilogy Financial LLC Takes $1.25 Million Position in Amgen Inc. $AMGN - MarketBeat

06:24 AM
pulisher
04:17 AM

Baader Bank Aktiengesellschaft Lowers Position in Amgen Inc. $AMGN - MarketBeat

04:17 AM
pulisher
Feb 12, 2026

UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen (AMGN) - simplywall.st

Feb 12, 2026
pulisher
Feb 12, 2026

Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

AMGN: Advancing late-stage trials and expanding TSLP-targeted therapies, with major data readouts ahead - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

Traders Buy Large Volume of Amgen Call Options (NASDAQ:AMGN) - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Amgen wins EC approval for Uplizna in gMG - The Pharma Letter

Feb 12, 2026
pulisher
Feb 12, 2026

Amgen wins EC approval for Uplinza in gMG - The Pharma Letter

Feb 12, 2026
pulisher
Feb 12, 2026

Varma Mutual Pension Insurance Co Buys 7,300 Shares of Amgen Inc. $AMGN - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS - PR Newswire

Feb 12, 2026
pulisher
Feb 12, 2026

Leuthold Group LLC Purchases New Stake in Amgen Inc. $AMGN - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Stratos Wealth Partners LTD. Has $8.83 Million Stake in Amgen Inc. $AMGN - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Cibc World Market Inc. Grows Stake in Amgen Inc. $AMGN - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

ABC Arbitrage SA Cuts Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Feb 12, 2026
pulisher
Feb 11, 2026

Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings - Nasdaq

Feb 11, 2026
pulisher
Feb 11, 2026

Amgen (NASDAQ:AMGN) Price Target Raised to $295.00 - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Rhumbline Advisers Sells 6,685 Shares of Amgen Inc. $AMGN - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52 - simplywall.st

Feb 11, 2026
pulisher
Feb 11, 2026

Prospera Financial Services Inc Sells 6,723 Shares of Amgen Inc. $AMGN - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Caprock Group LLC Makes New Investment in Amgen Inc. $AMGN - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Wealthfront Advisers LLC Grows Stock Position in Amgen Inc. $AMGN - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Amgen Inc. $AMGN Stock Holdings Reduced by Allegheny Financial Group - MarketBeat

Feb 11, 2026
pulisher
Feb 10, 2026

How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - Stock Traders Daily

Feb 10, 2026
pulisher
Feb 10, 2026

AstraZeneca Unit Settles Soliris Feud With Samsung, Amgen - Law360

Feb 10, 2026
pulisher
Feb 10, 2026

Mizuho Raises Price Target on Amgen to $295 From $280, Keeps Outperform Rating - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Daiwa Securities Group Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Just Two Days Till Amgen Inc. (NASDAQ:AMGN) Will Be Trading Ex-Dividend - 富途牛牛

Feb 10, 2026
pulisher
Feb 10, 2026

United States Biotechnology Market to hit US$ 1.5 Trillion - openPR.com

Feb 10, 2026
pulisher
Feb 10, 2026

Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend - simplywall.st

Feb 10, 2026
pulisher
Feb 10, 2026

Daiwa Securities Adjusts Price Target on Amgen to $410 From $370, Maintains Outperform Rating - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

The 5 Most Interesting Analyst Questions From Amgen's Q4 Earnings Call - Finviz

Feb 10, 2026
pulisher
Feb 10, 2026

The 5 Most Interesting Analyst Questions From Amgen’s Q4 Earnings Call - The Globe and Mail

Feb 10, 2026
pulisher
Feb 10, 2026

Alps Advisors Inc. Has $5.29 Million Stake in Amgen Inc. $AMGN - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Wesbanco Bank Inc. Increases Stake in Amgen Inc. $AMGN - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

First National Trust Co Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Amgen Inc. (NASDAQ:AMGN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 10, 2026
pulisher
Feb 09, 2026

Amgen stands by vasculitis drug Tavneos after FDA wants it pulled - ANCA Vasculitis News

Feb 09, 2026
pulisher
Feb 09, 2026

When Advocacy Meets Science in the Care of People Living with gMG - Amgen

Feb 09, 2026
pulisher
Feb 09, 2026

Amgen, Merck share losses contribute to Dow's 200-point drop - MSN

Feb 09, 2026
pulisher
Feb 09, 2026

Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN

Feb 09, 2026
pulisher
Feb 09, 2026

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance

Feb 09, 2026
pulisher
Feb 09, 2026

Candriam S.C.A. Cuts Holdings in Amgen Inc. $AMGN - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

ProShare Advisors LLC Sells 158,994 Shares of Amgen Inc. $AMGN - MarketBeat

Feb 09, 2026
pulisher
Feb 08, 2026

Amgen stock jumps to a 52-week high; here’s what to watch before Monday’s open - TechStock²

Feb 08, 2026
pulisher
Feb 08, 2026

Kinsale Capital Group Inc. Has $9.65 Million Stock Position in Amgen Inc. $AMGN - MarketBeat

Feb 08, 2026
pulisher
Feb 08, 2026

Bessemer Group Inc. Acquires 2,967 Shares of Amgen Inc. $AMGN - MarketBeat

Feb 08, 2026
pulisher
Feb 07, 2026

Amgen stock price hits 52-week high after Friday rally — what to watch into Monday - TechStock²

Feb 07, 2026
pulisher
Feb 07, 2026

The Truth About Amgen Inc.: Is This Quiet Biotech Giant Your Next Power Move? - AD HOC NEWS

Feb 07, 2026
pulisher
Feb 07, 2026

Amgen’s Stock Is Already Up 14% in 2026: Why Analysts Expect $440 - TIKR.com

Feb 07, 2026
pulisher
Feb 07, 2026

Twin Capital Management Inc. Sells 5,541 Shares of Amgen Inc. $AMGN - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

Renaissance Group LLC Lowers Position in Amgen Inc. $AMGN - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

SBI Securities Co. Ltd. Has $977,000 Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today - Sahm

Feb 07, 2026
pulisher
Feb 07, 2026

Amgen (NASDAQ:AMGN) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

Feb 07, 2026
pulisher
Feb 06, 2026

CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists - Reuters

Feb 06, 2026
pulisher
Feb 06, 2026

P/E Ratio Insights for Amgen - Benzinga

Feb 06, 2026
pulisher
Feb 06, 2026

Amgen (AMGN) Sees Target Price Increase by Argus Research | AMGN Stock News - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder - Benzinga

Feb 06, 2026
pulisher
Feb 06, 2026

Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Amgen Advances Xaluritamig Into Early-Stage Trial for Hard-to-Treat Ewing Sarcoma - TipRanks

Feb 06, 2026
pulisher
Feb 06, 2026

Amgen (AMGN) Target Price Raised by Guggenheim Analyst | AMGN St - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Amgen (NASDAQ:AMGN) Price Target Raised to $347.00 - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Guggenheim Adjusts Price Target on Amgen to $347 From $305, Maintains Neutral Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Argus Research Adjusts Price Target on Amgen to $400 From $360, Maintains Buy Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Aurdan Capital Management LLC Sells 5,316 Shares of Amgen Inc. $AMGN - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

3,190 Shares in Amgen Inc. $AMGN Acquired by ABN AMRO Bank N.V. - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Biotechnology Market Set to Witness Significant Growth by 2026-2033 | Amgen Inc., GlaxoSmithKline - EIN News

Feb 06, 2026
$154.12
price up icon 1.04%
drug_manufacturers_general NVO
$49.42
price up icon 1.02%
drug_manufacturers_general PFE
$27.79
price up icon 0.95%
drug_manufacturers_general MRK
$121.92
price up icon 2.32%
drug_manufacturers_general NVS
$161.85
price up icon 0.43%
자본화:     |  볼륨(24시간):